China-U.S. Precision Medicine Summit

Plenary in the morning

8:00 a.m.	Sign up and Networking
8:30 a.m.	Welcome and VIP Introduction
8:30 a.m.	Opening Remarks
	Dr. Martin J. Murphy	Summit Co-Chair, Chief Executive Officer, CEO Roundtable on Cancer
	Dr. WANG Chen	Summit Co-Chair, President, China Academy of Medical Sciences and Peking Union Medical College
	Terry Branstad	United States Ambassador to China
8:45 a.m.	Sponsor Remarks
	Mark Stevenson	Executive Vice President and Chief Operating Officer, Thermo Fisher Scientific
Session One: Ending Cancer needs China - U.S. Collaboration on Precision Medicine
8:50 a.m.	Keynote speech: Preventing Cervical Cancer in China, the United States and Globally
	Dr. Douglas Lowy   Deputy Director National Cancer Institute
9:15 a.m.	Keynote speech: Research and Development of a Precise Anti-Cancer Drug - Our Experience and Strategy
	Prof. LI Jin   President of Chinese Society for Clinical Oncology, Director, Medical Oncology, East Hospital Tongji University
9:40 a.m.	Panel discussion International Framework on Precision Medicine with Outstanding Contribution from China and U.S.
	Moderator
	Dr. Martin J. Murphy	Chief Executive Officer; CEO Roundtable on Cancer
	Panelists
	Dr. WANG Chen	President China Academy of Medical Sciences and Peking Union Medical College
	Dr. Douglas Lowy	Deputy Director National Cancer Institute
	Prof. LI Jin	President of Chinese Society for Clinical Oncology Director, Medical Oncology, East Hospital Tongji University
	Dr. WANG Yu	Former Director General Chinese Center for Disease Control and Prevention
10:10 a.m.	Coffee Break
Session Two: Accelerating Precision Medicine – Roles and Responsibilities of Industry, Academia and the Clinic
10:40 a.m.	Keynote speech: The Future of Precision Medicine on Cancer Research in China
	Prof. ZHAN Qimin   President, Peking University Health Science Center (PKUHSC) Vice President, Peking University
11:05 a.m.	Keynote speech: Value of a Dynamic Precision Medicine Eco System for a Healthier China
	Tony Acciarito   President, Thermo Fisher Scientific China
11:30 a.m.	Keynote speech: Transform the Oncology Research to Real Clinical Benefit for Patients – Experience from Industry
	Dr. Steffan Ho   Vice President and Head of the Translational Oncology Group Pfizer
11:55 a.m.	Panel discussion Looking Towards a World Without Cancer
	Moderator
	Dr. Corina Shtir	Head of Precision Medicine, Thermo Fisher Scientific
	Panelists
	Dr. Joseph Eid	Global Head of Medical Affairs, Bristol Myers Squibb (BMS)
	Dr. Matthew D. Brown	Director, China Office, Center for Global Health, National Cancer Institute, National Institutes of Health
	Prof. LIU Yuanli	Dean, School of Public Health, China Academy of Medical Sciences and Peking Union Medical College
	Prof. Dong Zigang	Executive Director, The Hormel Institute, University of Minnesota, McKnight Presidential Professor of Cancer Prevention, Hormel/Knowlton Professor, I. J. Holton Professor
12:25 p.m.	Luncheon

Plenary in the afternoon

1:45 p.m.	Keynote speech: Single Cell Genomics: MALBAC in Reproductive Health and Inherited Disease
	Prof. QIAO Jie   President, Peking University Third Hospital Academician of China Academy of Engineering
2:05 p.m.	Keynote speech: Metagenomics - Reproductive Health and Inherited Disease
	Prof. LIAO Can   President, Guangzhou Women and Children’s Medical Center
2:25 p.m.	Keynote speech: Oncology: Biomarker Selection in Cancer Diagnosis and Therapy
	Prof. QIN Jun   Director, National Center for Protein Science Beijing
2:45 p.m.	Panel Discussion: Technical Advances Shaping Precision Medicine
	Moderator
	Prof. Bruce Ling	Director Translational Medicine Stanford University
	Panelists
	Dr. Todd Hembrough	President, Proteomics, NantOmics, LLC
	William Liang	Vice President, Head of China Oncology AstraZeneca
	Prof. Andrew Kasarskis	Director, Icahn Institute for Genomics and Multiscale Biology
	Prof. Catherine Wong	Director of Precision Medicine Multi-Omics Center, Peking University Health Science Center
	Dr. CAI Long	President, National Health and Medicine Big Data (Nanjing) Center
	Prof. Nam Do Hyun	Director Samsung Institute of Refractory Cancer
3:25 p.m.	Coffee Break
3:55 p.m.	Keynote speech: Precise Diagnosis and Treatment of Pediatric Cancer: Real World Experience at Children’s Hospital Los Angeles
	Prof. Timothy Triche   Professor, Pathology and Pediatrics, Keck School of Medicine at USC and Co-Director, Center for Personalized Medicine, Childrens, Hospital Los Angeles (CHLA)
4:15 p.m.	Keynote speech: Promise of CAR T-Cell Therapy for the Treatment of Cancer
	Prof. ZHAO Yangbing   Director, T Cell Engineering Laboratory, Department of Pathology and Laboratory Medicine University of Pennsylvania School of Medicine
4:35 p.m.	Keynote speech: Precise Prevention of Cervical Cancer and HPV Vaccination in China
	Prof. QIAO Youlin Director for Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College
4:55 p.m.	Panel discussion: Impact of Digital Health for Precision Medicine
	Moderator
	Dr. Alan Sachs	Chief Scientific Officer, Thermo Fisher Scientific
	Panelists
	Prof. LI Yixue	Director, Shanghai Center for Bioinformation Technology
	Dr. YANG Hongwei	Former Deputy Director China National Health Development Research Center
	Dr. Frank Su	Founding Partner of Redhill Capital
	Dr. Seth Sadis	Director, Oncology Informatics and Software, Clinical Sequencing Division Thermo Fisher Scientific
5:35 p.m.	Closing Remark by Chairman and Event Ends